“This Is Not a Farm”: Farmers Call out €386bn EU Policy as Small Farms Vanish – WeMove Europe
3.6.2025 06:00:00 CEST | Business Wire | Press Release
A series of Magritte-inspired Surrealist artwork appeared outside the European Parliament – confronting policymakers with a visual warning about the future of farming in Europe, and a call to align the EU’s €386 billion farm subsidy system with the Green Deal. WeMove Europe, the independent campaign group made up of more than 750,000 people across Europe behind the stunt, have called for urgent CAP reform — demanding fairer subsidies, stronger market regulation, and greater support for sustainable, small-and medium-sized farms.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250602570459/en/
BRUSSELS, BELGIUM: Sinister Portrayal Of Industrial Agriculture appears outside European Parliament as WeMove Europe calls for reforms to EU Farming policies in Brussels, Belgium. (Photo by Geert Vanden Wijngaert/Getty Images for WeMove Europe)
The action is backed by a coalition of farmer groups, environmental organisations and over 100,000 citizens across Europe. They argue the current subsidy system rewards intensive agriculture at the expense of small and sustainable farms. More than five million farms have disappeared across the EU since 2005, while 80% of CAP funds go to just 20% of recipients. Polling released earlier this year shows up to 70% of farmers in Spain, Italy and Poland feel forgotten by policymakers — despite most expressing pride in their work and support for environmental action.
Morgan Ody,a vegetable producer from Bretagne, France, and member of European Coordination Via Campesina (ECVC), says: “Alongside ensuring fair prices, a strong CAP budget is essential to tackle the challenges farmers face today. But that public money must be used to keep rural areas alive by regulating markets and supporting the transition to agroecology and more sustainable food systems – not to fuel the industrialisation of farming or line shareholders’ pockets.”
Styled in homage to Magritte’s famous ‘Treachery of Images’, the artworks unveiled carry captions such as “Ceci n’est pas une pomme” and “Ceci n’est pas une ferme”. Their message: Europe’s farm policy no longer feeds people — it feeds corporate consolidation. The full collection is viewable at www.notfarming.com. The aim is to challenge outdated “postcard” perceptions of farming — and spark honest discussion among policymakers about who the current system really serves.
In many European areas, one in three farms has ceased operations, while subsidised overproduction drives prices so low that some farmers earn less than it costs them to produce. In France and Spain, for example, milk is often sold below production cost — a market failure propped up by the CAP.
Giulio Carini, communications manager at WeMove Europe says: “Our farming system is rigged. Small farmers are being pushed off the land while agribusiness giants cash in on public money. Discussions about the future of the CAP need to address what we are paying for, not just how much money is allocated to it. We need to support farmers and reward them for protecting our nature and climate, on which they rely. We’re calling on people across Europe to stand up for fair prices, healthy food, and a future where small sustainable farmers and nature can thrive. This is our moment to demand our EU leaders fix this broken system.”
In full, the coalition is calling for:
- Fair prices for farmers that reflect the full cost of sustainable food production
- Stronger market regulation, including supply management and minimum price guarantees
- Greater support for small and medium-sized farms over industrial agribusiness
- A just transition to agroecology to protect soil health, climate, biodiversity, and food sovereignty
- Access to healthy, sustainable food for all, ensuring that good food is affordable and available, and that people can make real choices about what they eat, without hidden environmental or health costs.
These reforms are essential not only for securing farmers’ futures, but also for delivering on the EU Green Deal — ensuring that Europe’s food system supports climate, nature and communities alike.
People across Europe can urge the EU to act by signing the petition at www.notfarming.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250602570459/en/
Contacts
info@wemove.eu
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom